Breast Cancer
Conference Coverage
Repeat MCED Testing May ID Early-Stage and Unscreened Cancers
Eight of 26 patients with cancer signals detected through MCED had cancer.
Conference Coverage
ImPrint Identifies Patients With Breast Cancer Likely to Respond to Neoadjuvant Immunotherapy
Experts discuss the first randomized clinical study to assess the efficacy of immunotherapy in patients with HR+/HER2- breast cancer.
From the Journals
Less Than 50% of Accelerated Approvals Show Clinical Benefit
Researchers review 46 cancer drugs granted accelerated approvals between 2013 and 2017.
News from the FDA/CDC
FDA Expands Enhertu Indication to HER2-Positive Solid Tumors
The agent had already been approved for several cancer types.
Feature
Do Tumor-infiltrating Lymphocytes Predict Better Breast Cancer Outcomes?
A new study evaluates whether TILs can identify a subset of patients with triple-negative breast cancer with a very low risk of cancer recurrence...
From the Journals
Virtual Reality Brings Relief to Hospitalized Patients With Cancer
Patients were randomized to receive either 10 minutes of immersive VR distraction therapy or 10 minutes of two-dimensional guided imagery...
Feature
Should Opioids Be Used for Chronic Cancer Pain?
Prescribing strategies are partly driven by peer pressure, new research suggests.
Latest News
Older, Breastfeeding Mothers Face Differing Advice About Mammograms
Most national guidelines support routine mammograms for breastfeeding moms, but protocols in the practice setting may differ.
From the Journals
Polygenic Risk Scores Improve Breast Cancer Screening
Researchers examine how well polygenic risk scores predict a person's risk for any breast cancer as well as invasive, in situ, and bilateral at...
Commentary
A Banned Chemical That Is Still Causing Cancer
This carcinogen ‘is still around: in our soil, in our food, and in our blood.’
From the Journals
Active Surveillance for Cancer Doesn’t Increase Malpractice Risk
Researchers identify malpractice trends involving active surveillance related to thyroid, prostate, kidney, and...